At the San Antonio Breast Cancer Symposium in 2025. We saw the results of the lidERA study, which looked at the oral SERD ...
And so we really need more research into how to optimize these patients long-term, especially when we generally do not use menopausal hormone therapy in hormone receptor positive breast cancer.
Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy found that ...
Scientists at Duke-NUS Medical School and the National University Health System (NUHS), together with an international team ...
A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening ...
Why do some tumours spread while others remain localised? The mechanisms governing the metastatic potential of tumour cells remain largely unknown — yet understanding this is crucial for optimising ...
Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells ...
Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback